C H Tator, R O Heimbecker. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AngiographyArm/blood supplyDextrans/therapeutic useErgotamine/adverse effectsErgotism/drug therapyHeparin/therapeutic useHumansIschemia/chemically inducedMaleMepivacaine/therapeutic useMiddle AgedTolazoline/therapeutic use
Substances: See more » DextransHeparinMepivacaineTolazolineErgotamine
Year: 1966 PMID: 5928531 PMCID: PMC1935854
Source DB: PubMed Journal: Can Med Assoc J ISSN: 0008-4409 Impact factor: 8.262